drugset / Trial / NCT00955357
Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures
Non-randomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of oral Lacosamide as first add on treatment in subjects with uncontrolled partial-onset seizures after prior treatment with a monotherapy Antiepileptic Drug (AED) regimen compared to subjects who have received treatment with at least 2 AEDs.
Timeline
- Start
- 2009-08
- Primary completion
- 2013-04
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lacosamide | Other / unclassified | 150 mg | Oral |
| Subject | Lacosamide | Other / unclassified | 200 mg | Oral |